SGLT2 inhibitors generally offer superior renal protection and are recommended for patients with chronic kidney disease
This balancing effect provides welcome side benefits for those managing combination skin challenges
Prevalence and association analysis of obstructive sleep apnea with gender and age differences - Results of SHIP-Trend
Regional People with overweight, all classes of obesity, and T2D spotlighting the frequent concurrence of the two conditions Obesity x T2D overlap Wegovy and Zepbound are not FDA-approved to treat type 2 diabetes, but in clinical trials, in addition to losing weight, patients saw improvements in blood glucose levels
Li CX, Liang S, Gao L, et al
The emerging roles of platelet-derived extracellular vesicles in disease